Clincosm LogoSign in Get a demo

Cardiovascular Mortality Associated With Abnormal Calcium Metabolism

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00018395
Collaborator
(none)
1
Location
58
Duration (Months)

Study Details

Study Description

Brief Summary

The purpose of this cohort study is to estimate the risk of cardiovascular mortality associated with abnormal calcium metabolism

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Official Title:
    Cardiovascular Mortality Associated With Abnormal Calcium Metabolism
    Study Start Date :
    Aug 1, 1997
    Study Completion Date :
    Jun 1, 2002

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No

      All ESRD patients who indicated dialysis in 1990-1993

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 VA Puget Sound Health Care System Seattle Washington United States 98108

      Sponsors and Collaborators

      • US Department of Veterans Affairs

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00018395
      Other Study ID Numbers:
      • CADE-AI
      First Posted:
      Jul 5, 2001
      Last Update Posted:
      Jan 21, 2009
      Last Verified:
      Dec 1, 2004
      Keywords provided by , ,
      Calcium Metabolism
      Additional relevant MeSH terms:
      Kidney Diseases
      Cardiovascular Diseases

      Study Results

      No Results Posted as of Jan 21, 2009